Form D · Biotechnology

CALECO PHARMA CORP.

Long Valley, NJ · CIK 0001312402

Offering snapshot reported Jun 21, 2011 · SEC filing

Reported sold
$43.8K
Offering amount: $43.8K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 16, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 21, 2011Initial$43,750No comparison1SEC filing
Jun 21, 2011Initial$60,000No comparison1SEC filing
Mar 1, 2010Amendment$170,000$65,000vs Oct 16, 200911SEC filing
Mar 1, 2010Initial$81,000No comparison1SEC filing
Oct 16, 2009Initial$10,860No comparison1SEC filing
Oct 16, 2009Initial$105,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-161582
Deemed price of $0.07 per share, being the closing price of the Issuer's common stock on August 16, 2010.

Source: Form D, filed Jun 21, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Perry Augustson Promoter
Francisco Javier Benedi Garcia Director
John Boschert Director, Executive
Rolf G Horchler Promoter
Rudolf Mauer Promoter
James A Sandino Director
Luc Vanhal Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
59 East Mill Road, Building 4, Suite 201
Long Valley, NJ, 07853